CLASS II ONGOING Device recall · Reported 3 May 2023 · FDA Enforcement Report

Draeger Infinity CentralStation (ICS) recalled

Draeger Medical Systems is recalling Draeger Infinity CentralStation (ICS), centralized monitoring of adult, pediatric and, distributed nationwide in the US. The recall was initiated on 5 Apr 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 04049098001878; All Systems Running Software versions: ICS VG2.1.3 and lower
Quantity recalled6803 systems

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1471-2023
FDA event ID
91938
Recalling firm
Draeger Medical Systems, Andover, MA
Classification
Class II
Status
Ongoing
Recall initiated
5 Apr 2023
FDA classified
27 Apr 2023
Reported
3 May 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Patient Monitors

Timeline

5 Apr 2023Recall initiated by company
27 Apr 2023Classified by FDA+22 days
3 May 2023Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The software on the Infinity CentralStation drops peaks on narrow waveforms causing the Infinity M300 to fail to meet Frequency and Impulse Response requirements. In this condition, ECG waveforms with unusually narrow and/or high frequency QRS may be displayed or printed with QRS amplitudes intermittently lower than actual.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Draeger Infinity CentralStation (ICS), centralized monitoring of adult, pediatric and neonatal patient data within the hospital or clinical environment, Software versions VG2.1.3 and lower

Where it was distributed

Worldwide - US Nationwide distribution.

Nationwide

Questions about this recall

Is Draeger Infinity CentralStation (ICS), centralized monitoring of adult, pediatric and recalled?

Yes. Draeger Medical Systems recalled Draeger Infinity CentralStation (ICS), centralized monitoring of adult, pediatric and on 5 Apr 2023. The recall is Class II and its status is Ongoing. Recall number Z-1471-2023.

Why was it recalled?

The software on the Infinity CentralStation drops peaks on narrow waveforms causing the Infinity M300 to fail to meet Frequency and Impulse Response requirements. In this condition, ECG waveforms with unusually narrow and/or high frequency QRS may be displayed or printed with QRS amplitudes intermittently lower than actual.

Which lots are affected?

UDI-DI: 04049098001878; All Systems Running Software versions: ICS VG2.1.3 and lower

Where was it sold?

Worldwide - US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Draeger Medical Systems

All 12

Other Patient Monitors recalls

All 1,013